Loading stock data…
ICUI
$118.85-0.35 (-0.29%)
Market ClosedLast close May 1
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ICU Medical, Inc. in the Healthcare sector is trading at $118.85. The stock is currently 26% below its 52-week high of $160.29, remaining 11.1% below its 200-day moving average. Technical signals show neutral RSI of 31 and bearish MACD signal, explaining why ICUI maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 31) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$118.85
Potential Downside
99.6%
Whystock Fair Value$0.49
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Buy
Mean target$177.50+49.3%
Range$163.00 – $200.00
Fundamentals
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroCla...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.18B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
4245.33
Beta
Defensive asset. Lower volatility than the S&P 500.
0.85
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1.74%
Volume
Today's trading volume
204,096
Recent News
Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical Calls Itself a “Pure-Play Infusion” Leader, Details Pricing, Pumps and Buyback Plans
ICU Medical (NASDAQ:ICUI) executives highlighted the company’s evolution into what CEO Vivek Jain described as “the world’s only pure-play infusion company” during a fireside chat at the 25th Annual Needham Healthcare Conference, while also addressing pricing dynamics, product roadmaps, macro pressu
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Teardown: ICU Medical (NASDAQ:ICUI) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at ICU Medical (NASDAQ:ICUI) and its peers.
1 Small-Cap Stock to Keep an Eye On and 2 Facing Challenges
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.